Barclays’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-125
| Closed | -$1.42K | – | 5492 |
|
|
2025
Q1 | $1.42K | Sell |
125
-2,760
| -96% | -$50.1K | ﹤0.01% | 5019 |
|
|
2024
Q4 | $58.9K | Buy |
2,885
+622
| +27% | +$18.1K | ﹤0.01% | 4723 |
|
|
2024
Q3 | $89.8K | Buy |
+2,263
| New | +$60.9K | ﹤0.01% | 4601 |
|
|
2023
Q4 | – | Sell |
-7
| Closed | -$135 | – | 5327 |
|
|
2023
Q3 | $135 | Buy |
+7
| New | +$213 | ﹤0.01% | 4541 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5355 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5080 |
|
|
2021
Q4 | – | Sell |
-74
| Closed | -$5K | – | 4640 |
|
|
2021
Q3 | $5K | Sell |
74
-73
| -50% | -$5.54K | ﹤0.01% | 4602 |
|
|
2021
Q2 | $15K | Sell |
147
-383
| -72% | -$39.5K | ﹤0.01% | 4559 |
|
|
2021
Q1 | $68K | Buy |
530
+325
| +159% | +$48K | ﹤0.01% | 4130 |
|
|
2020
Q4 | $23K | Sell |
205
-87
| -30% | -$9.74K | ﹤0.01% | 4648 |
|
|
2020
Q3 | $35K | Sell |
292
-52
| -15% | -$9K | ﹤0.01% | 4749 |
|
|
2020
Q2 | $74K | Buy |
344
+110
| +47% | +$26K | ﹤0.01% | 4714 |
|
|
2020
Q1 | $52K | Sell |
234
-451
| -66% | -$129K | ﹤0.01% | 5211 |
|
|
2019
Q4 | $184K | Buy |
685
+350
| +104% | +$88K | ﹤0.01% | 5103 |
|
|
2019
Q3 | $102K | Buy |
335
+8
| +2% | +$2.46K | ﹤0.01% | 5463 |
|
|
2019
Q2 | $108K | Buy |
327
+176
| +117% | +$89.4K | ﹤0.01% | 5632 |
|
|
2019
Q1 | $94K | Buy |
151
+70
| +86% | +$31.9K | ﹤0.01% | 5408 |
|
|
2018
Q4 | $20K | Sell |
81
-316
| -80% | -$126K | ﹤0.01% | 5901 |
|
|
2018
Q3 | $184K | Buy |
397
+365
| +1,141% | +$177K | ﹤0.01% | 5073 |
|
|
2018
Q2 | $17K | Sell |
32
-162
| -84% | -$97.1K | ﹤0.01% | 6277 |
|
|
2018
Q1 | $111K | Sell |
194
-32
| -14% | -$20.2K | ﹤0.01% | 5312 |
|
|
2017
Q4 | $144K | Buy |
226
+213
| +1,638% | +$150K | ﹤0.01% | 4959 |
|
|
2017
Q3 | $12K | Sell |
13
-61
| -82% | -$46.7K | ﹤0.01% | 6062 |
|
|
2017
Q2 | $64K | Sell |
74
-11
| -13% | -$9.01K | ﹤0.01% | 5206 |
|
|
2017
Q1 | $58K | Sell |
85
-5
| -6% | -$3.29K | ﹤0.01% | 5252 |
|
|
2016
Q4 | $64K | Sell |
90
-66
| -42% | -$45.6K | ﹤0.01% | 5010 |
|
|
2016
Q3 | $115K | Buy |
156
+1
| +0.6% | +$810 | ﹤0.01% | 4414 |
|
|
2016
Q2 | $130K | Buy |
155
+9
| +6% | +$8.37K | ﹤0.01% | 4226 |
|
|
2016
Q1 | $112K | Buy |
+146
| New | +$115K | ﹤0.01% | 4272 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | -$2.33K | – | 6478 |
|
|
2015
Q3 | $2K | Sell |
2
-134
| -99% | -$194K | ﹤0.01% | 6365 |
|
|
2015
Q2 | $239K | Sell |
136
-265
| -66% | -$337K | ﹤0.01% | 4025 |
|
|
2015
Q1 | $441K | Buy |
401
+358
| +833% | +$419K | ﹤0.01% | 3709 |
|
|
2014
Q4 | $47K | Buy |
43
+37
| +617% | +$38K | ﹤0.01% | 5776 |
|
|
2014
Q3 | $7K | Sell |
6
-1
| -14% | -$1.13K | ﹤0.01% | 7042 |
|
|
2014
Q2 | $9K | Sell |
7
-8
| -53% | -$9.62K | ﹤0.01% | 6884 |
|
|
2014
Q1 | $20K | Sell |
15
-527
| -97% | -$685K | ﹤0.01% | 6604 |
|
|
2013
Q4 | $597K | Sell |
542
-349
| -39% | -$481K | ﹤0.01% | 3921 |
|
|
2013
Q3 | $1.08M | Buy |
891
+519
| +140% | +$352K | ﹤0.01% | 3271 |
|
|
2013
Q2 | $148K | Buy |
+372
| New | +$158K | ﹤0.01% | 5463 |
|
Other funds holding RMTI
AC
GC
Barclays's RMTI Position: Q2 2025 in Review
Barclays sold out of Rockwell Medical (RMTI) in Q2 2025, closing a stake of 125 shares — an estimated $1.42K sold.
Barclays first reported a position in RMTI in Q2 2013 and held it in 37 quarters. The position peaked at $1.08M in Q3 2013. 41 funds tracked by Wall St. Rank hold RMTI as of Q2 2025.
- Barclays reported no remaining Rockwell Medical position as of Q2 2025 after selling out during the quarter.
- Barclays sold 125 Rockwell Medical shares in Q2 2025, an estimated $1.42K.
- Barclays first reported a position in Rockwell Medical in Q2 2013 and held it in 37 quarters.
- Barclays's Rockwell Medical position peaked at $1.08M in Q3 2013.
- 41 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2025.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.